Calcitonin gene-related peptide monoclonal antibody treatment for new daily persistent headache
Abstract Background New daily persistent headache (NDPH) is a rare headache disorder that often resembles chronic migraine (CM) phenotypically, but unlike CM is daily from onset. Several calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) have been proven to be effective in CM. It is n...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2025-07-01
|
| Cyfres: | The Journal of Headache and Pain |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s10194-025-02111-2 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|